SMAD1 and colorectal carcinoma: To our knowledge, this study is the first to provide evidence about the P8-Smad1-EMT regulatory network or cell adhesion axis in CRC metastasis, suggesting that P8 is a potential new biotherapeutic agent and Smad1 is a potential prognostic factor for CRC metastasis [29].